Denosumab achieves structural modification in erosive hand osteoarthritis
PHILADELPHIA — Denosumab successfully induces structural modifications patients with active erosive hand osteoarthritis, according to data presented at ACR Convergence 2022.
PHILADELPHIA — Denosumab successfully induces structural modifications patients with active erosive hand osteoarthritis, according to data presented at ACR Convergence 2022.
(cLBP) are sparse and inconsistent. To address this limitation, we assessed IAFs in a cohort of 70 individuals with cLBP, implemented 3 different IAF calculations,…
Vasculitides have long posed significant diagnostic and therapeutic challenges for clinicians due to their complex nature. During the past two decades, the mechanisms driving these…
SAN DIEGO — Transplant physicians should have a patient care plan in place when helping patients deal with the distress and anxiety after a failed…
Objective Uveitis is a common extra-articular manifestation of axial spondylarthritis (AxSpA). We set to evaluate risk of anterior uveitis (AU) with biologics and synthetic disease-modifying…
Disruptions in endothelial function caused by brief bouts of elicited anger may be an early predictor of heart disease, but the underlying mechanism remains unclear,…
Background: Delamination of rotator cuff tears during arthroscopic shoulder surgery has an incidence of 38% to 92%. Double-layer (DL) repair and en masse (EM) r…
ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from…
The month of May serves as Arthritis Awareness Month, drawing attention to this all-too common, yet misunderstood, condition.Although misconceptions may lead people to discount the…
Facilitated telemedicine integrated into opioid treatment programs for patients with hepatitis C virus infection resulted in “substantially higher” cure rates compared with offsite referral to…